IMMUNOME, INC. IMNM 深 滬
等待開盤 10-21 09:30:00 美东时间
16.25
+0.580
+3.70%
華盛通- 最 高16.29
- 今 開16.248
- 成交量 79.07万股
- 最 低 15.49
- 昨 收 15.67
- 總市值 14.14亿
- 52周最高 17.0766
- 市盈率 靜 --
- 換手率 0.91%
- 52周最低 5.1501
- 委 比 -76.19%
- 總股本 8704.50万
- 歷史最高 63.78
- 量 比 0.61
- 振 幅 5.11%
- 歷史最低 2.09
- 每 手 1
- 風險率 4.95%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Breaking Down Gilead Sciences: 6 Analysts Share Their Views
Providing a diverse range of perspectives from bullish to bearish, 6 analysts h...
10-09 06:01
Market Whales and Their Recent Bets on GILD Options
Investors with a lot of money to spend have taken a bearish stance on Gilead Sc...
10-03 02:01
美股大行评级 | 潜在涨幅1650.0%！Ascendiant Capital维持GRI Bio"买入"评级，目标价上调至35美元
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从34美元升至35美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.5美元升至7.75美元
09-23 09:52
Goldman Sachs Initiates Coverage On Immunome with Buy Rating, Announces Price Target of $26
Goldman Sachs analyst Salveen Richter initiates coverage on Immunome (NASDAQ:IMNM) with a Buy rating and announces Price Target of $26.
09-22 19:57
What Analysts Are Saying About Gilead Sciences Stock
Gilead Sciences (NASDAQ:GILD) underwent analysis by 5 analysts in the last quar...
09-16 21:01
Where Immunome Stands With Analysts
Immunome (NASDAQ:IMNM) underwent analysis by 4 analysts in the last quarter, re...
09-06 05:02
Craig-Hallum Initiates Coverage On Immunome with Buy Rating, Announces Price Target of $26
Craig-Hallum analyst Adam Vogel initiates coverage on Immunome (NASDAQ:IMNM) with a Buy rating and announces Price Target of $26.
09-05 22:05
Immunome (IMNM) Initiated with a Buy at Craig-Hallum
In a report released today, from Craig-Hallum initiated coverage with a Buy rat...
09-05 21:15
美股大行评级 | 英伟达、Snowflake、万国数据、沃尔玛、Target等均获大行上调目标价
今日重点评级关注：杰富瑞：维持aTyr Pharma"买入"评级，目标价从9美元升至17美元；花旗：维持Ionis制药"买入"评级，目标价从65美元升至69美元
08-25 08:34
Evercore ISI Group Initiates Coverage On Immunome with Outperform Rating, Announces Price Target of $18
Evercore ISI Group analyst Cory Kasimov initiates coverage on Immunome (NASDAQ:IMNM) with a Outperform rating and announces Price Target of $18.
08-23 00:50
